Yuan Gao

Years Active: 2023-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Yuan Gao, Youling Li, Yunhe Zhu, Qiao Luo, Yifeng Lu, Ke Wen, Boyu Du, Xueyan Xi, Gang Li
Emodin is a Potential Drug Targeting CD44-positive Hepatocellular Cancer. Current cancer drug targets 24 (5) (2024)
Yuan Gao, Youling Li, Yunhe Zhu, Qiao Luo, Yifeng Lu, Ke Wen, Boyu Du, Xueyan Xi, Gang Li
Emodin is a Potential Drug Targeting CD44-positive Hepatocellular Cancer. Current cancer drug targets 24 (5) (2024)
Yuan Gao, Youling Li, Yunhe Zhu, Qiao Luo, Yifeng Lu, Ke Wen, Boyu Du, Xueyan Xi, Gang Li
Emodin is a Potential Drug Targeting CD44-positive Hepatocellular Cancer. Current cancer drug targets 24 (5) (2024)
Yuan Gao, Youling Li, Yunhe Zhu, Qiao Luo, Yifeng Lu, Ke Wen, Boyu du, Xueyan Xi, Gang Li
Emodin is a Potential Drug Targeting CD44-positive Hepatocellular Cancer. Current cancer drug targets (2023)

Yuan Gao.css-eqlu8i{font-size:small;padding-left:4px;}